Catechol-O-methyltransferase Val 108/158 Met polymorphism and breast cancer risk: A case control study in Syria

Breast Cancer

Volumn 20, Issue 1, 2013, Pages 62-66

  Lajin, Bassam ^a   Hamzeh, Abdul Rezzak ^a   Ghabreau, Lina ^a   Mohamed, Ali ^b   Al Moustafa, Ala Eddin ^a,c,d   Alachkar, Amal ^a  

^a UNIVERSITY OF ALEPPO   (Syrian Arab Republic)

^b Oncosurgery   (Syrian Arab Republic)

^c Research Cancer Centre of the Syrian Society Against Cancer   (Syrian Arab Republic)

^d MCGILL UNIVERSITY   (Canada)

Author keywords

Breast cancer; COMT; Polymorphism; Syrian patients; Val158Met

Indexed keywords

CATECHOL METHYLTRANSFERASE; METHIONINE; VALINE;

ADULT; ARTICLE; BREAST CANCER; CANCER RISK; CANCER SUSCEPTIBILITY; CASE CONTROL STUDY; CATECHOL METHYLTRANSFERASE GENE; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; POPULATION RESEARCH; PRIORITY JOURNAL; SYRIAN ARAB REPUBLIC;

ADULT; BREAST NEOPLASMS; CASE-CONTROL STUDIES; CATECHOL O-METHYLTRANSFERASE; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MIDDLE AGED; POLYMORPHISM, GENETIC; SYRIA;

EID: 84872606391     PISSN: 13406868     EISSN: 18804233     Source Type: Journal    
DOI: 10.1007/s12282-011-0309-y     Document Type: Article

References (36)

1. Boyle P, Ferlay J. Cancer incidence and mortality in Europe. Ann Oncol. 2005;(16):481e8.
2. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM, GLOBOCAN. Cancer incidence and mortality worldwide: IARC Cancer Base No. 10; 2008.
3. Sorlie T, Perou CM, Tibshirani R, Aas T, Geisler S, Johnsen H, et al. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci USA. 2001;98(19):10869-74. (Pubitemid 32878711)
4. Surveillance, Epidemiology, and End Results (SEER) Program http://www.seer.cancer.gov SEER*Stat Database. 2008. http://seer.cancer. gov/seerstat.
5. Vilaprinyo E, Rue M, Marcos-Gragera R, Martinez-Alonso M. Estimation of age- and stage-specific Catalan breast cancer survival functions using US and Catalan survival data. BMC Cancer. 2009;9(1):98.
6. Li CI, Malone KE, Daling JR. Differences in breast cancer stage, treatment, and survival by race and ethnicity. Arch Intern Med. 2003;163(1):49-56. (Pubitemid 36091600)
7. Zabaleta J, Schneider BG, Ryckman K, Hooper PF, Camargo MC, Piazuelo MB, et al. Ethnic differences in cytokine gene polymorphisms: potential implications for cancer development. Cancer Immunol Immunother. 2008;57(1):107-14. (Pubitemid 350043653)
8. DeChello LM, Gregorio DI, Samociuk H. Race-specific geography of prostate cancer incidence. Int J Health Geogr. 2006;5:59. (Pubitemid 46165490)
9. Yager JD, Davidson NE. Estrogen carcinogenesis in breast cancer. New Engl J Med. 2006;354(3):270-82. (Pubitemid 43113032)
10. Lachman HM, Papolos DF, Saito T, Yu YM, Szumlanski CL, Weinshilboum RM. Human catechol-O-methyltransferase pharmacogenetics: description of a functional polymorphism and its potential application to neuropsychiatric disorders. Pharmacogenetics. 1996;6:243-50. (Pubitemid 26226317)
11. Kocabas NA, Sardas S, Cholerton S, Daly AK, Karakaya AE. Cytochrome P450 CYP1B1 and catechol O-methyltransferase (COMT) genetic polymorphisms and breast cancer susceptibility in a Turkish population. Arch Toxicol. 2002;76:643-9. (Pubitemid 35471789)
12. Thompson PA, Shields PG, Freudenheim JL, Stone A, Vena JE, Marshall JR, et al. Genetic polymorphisms in catechol-Omethyltransferase, menopausal status, and breast cancer risk. Cancer Res. 1998;58:2107-10. (Pubitemid 28232895)
13. Millikan RC, Pittman GS, Tse CK, Duell E, Newman B, Savitz D, et al. Catechol-O-methyltransferase and breast cancer risk. Carcinogenesis. 1998;19:1943-7. (Pubitemid 28521935)
14. Huang CS, Chern HD, Chang KJ, Cheng CW, Hsu SM, Shen CY. Breast cancer risk associated with genotype polymorphism of the estrogen-metabolizing genes CYP17, CYP1A1, and COMT: a multigenic study on cancer susceptibility. Cancer Res. 1999;59:4870-5.
15. Hamajima N, Matsuo K, Tajima K, Mizutani M, Iwata H, Iwase T, et al. Limited association between a catechol-O-methyltransferase (COMT) polymorphism and breast cancer risk in Japan. Int J Clin Oncol. 2001;6:13-8. (Pubitemid 32230357)
16. Mitrunen K, Jourenkova N, Kataja V, Eskelinen M, Kosma VM, Benhamou S, et al. Polymorphic catechol-O-methyltransferase gene and breast cancer risk. Cancer Epidemiol Biomarkers Prev. 2001;10:635-40. (Pubitemid 32703197)
17. Bergman-Jungestrom M, Wingren S. Catechol-O-methyltransferase (COMT) gene polymorphism and breast cancer risk in young women. Br J Cancer. 2001;85:859-62. (Pubitemid 33010553)
18. Yim DS, Parkb SK, Yoo KY, Yoon KS, Chung HH, Kang HL, et al. Relationship between the Val158Met polymorphism of catechol O-methyl transferase and breast cancer. Pharmacogenetics. 2001;11:279-86. (Pubitemid 32537400)
19. Mao C, Wang XW, Qiu LX, Liao RY, Ding H, Chen Q. Lack of association between catechol-O-methyltransferase Val108/158Met polymorphism and breast cancer risk: a metaanalysis of 25, 627 cases and 34, 222 controls. Breast Cancer Res Treat. 2010;121:719-25.
20. Yager JD. Endogenous estrogens as carcinogens through metabolic activation. J Natl Cancer Inst Monogr. 2000;(27):67-73.
21. Liehr JG. Is estradiol a genotoxic mutagenic carcinogen? Endocr Rev. 2000;21:40-54. (Pubitemid 32260395)
22. Hoffman A, Paul S, Axelrod J. Catechol estrogen synthesis and metabolism by human breast tumors in vitro. Cancer Res. 1979;39:4584-7. (Pubitemid 10198635)
23. Amin A, Creveling C, Lowe M. Immunohistochemical localization of catechol methyltransferase in normal and cancerous breast tissues of mice and rats. J Natl Cancer Inst. 1983;70:337-42. (Pubitemid 13164031)
24. Lavigne JA, Goodman JE, Fonong T, Odwin S, He P, Roberts DW, et al. The effects of catechol-O-methyltransferase inhibition on estrogen metabolite and oxidative DNA damage levels in estradioltreated MCF-7 cells. Cancer Res. 2001;61:7488-94. (Pubitemid 32995038)
25. Lavigne JA, Helzlsouer KJ, Huang HY, Strickland PT, Bell DA, Selmin O, et al. An association between the allele coding for a low activity variant of catechol-O-methyltransferase and the risk for breast cancer. Cancer Res. 1997;57:5493-7. (Pubitemid 28006754)
26. Sazci A, Ergul E, Kucukali I, Kilic G, Kaya G, Kara I, et al. Catechol-O-methyltransferase Val 108/158 Met polymorphism in premenopausal breast cancer patients. Toxicology. 2004;204(2-3):197-202. (Pubitemid 39244079)
27. Wedren S, Rudqvist TR, Granath F, Weiderpass E, Ingelman-Sundberg M, Persson I, et al. Catechol-O-methyltransferase gene polymorphism and post-menopausal breast cancer risk. Carcinogenesis. 2003;24:681-7. (Pubitemid 36592403)
28. Lin WY, Chou YC, Wu MH, Jeng YL, Huang HB, You SL, et al. Polymorphic catechol-O-methyltransferase gene, duration of estrogen exposure, and breast cancer risk: a nested case-control study in Taiwan. Cancer Detect Prev. 2005;29(5):427-32. (Pubitemid 41406137)
29. Onay V, Briollais L, Knight JA, Shi E, Wang Y, Wells S, et al. SNP-SNP interactions in breast cancer susceptibility. BMC Cancer. 2006;6(1):114. (Pubitemid 46277079)
30. Listgarten J, Damaraju S, Poulin B, Cook L, Dufour J, Driga A, et al. Predictive models for breast cancer susceptibility from multiple single nucleotide polymorphisms. Clin Cancer Res. 2004;10(8):2725-37. (Pubitemid 38509148)
31. Easton DF, Pooley KA, Dunning AM, Pharoah PD, Thompson D, Ballinger DG, et al. Genome-wide association study identifies novel breast cancer susceptibility loci. Nature. 2007;447(7148):1087-93. (Pubitemid 47014426)
32. Coughlin SS, Piper M. Genetic polymorphisms and risk of breast cancer. Cancer Epidemiol Biomarkers Prev. 1999;8(11):1023-32. (Pubitemid 29536097)
33. Shields PG, Harris CC. Cancer risk and low-penetrance susceptibility genes in gene-environment interactions. J Clin Oncol. 2000;18(11):2309-15. (Pubitemid 30350224)
34. Beggs AD, Hodgson SV. Genomics and breast cancer: the different levels of inherited susceptibility. Eur J Hum Genet. 2008;17(7):855-6.
35. Palmatier MA, Kang AM, Kidd KK. Global variation in the frequencies of functionally different catechol-O-methyltransferase alleles. Biol Psychiatry. 1999;46(4):557-67. (Pubitemid 29370449)
36. Lajin B, Sakur AA, Hamzeh AR, Alachkar A. Genotype distribution of the single nucleotide polymorphism Val158Met of the COMT gene in the Syrian population. J Biol Sci. 2010;10:701-4.